In vitro pharmacodynamic models to determine the effect of antibacterial drugs

被引:74
作者
Gloede, Julia [1 ]
Scheerans, Christian [1 ,2 ]
Derendorf, Hartmut [3 ]
Kloft, Charlotte [1 ,2 ]
机构
[1] Univ Halle Wittenberg, Inst Pharm, Dept Clin Pharm, D-06120 Halle, Germany
[2] Free Univ Berlin, Inst Pharm, Dept Clin Pharm, D-1000 Berlin, Germany
[3] Univ Florida, Coll Pharm, Dept Pharmaceut, Gainesville, FL 32610 USA
关键词
in vitro models; antibiotics; dilution models; dialysis; diffusion models; static models; RESISTANT STAPHYLOCOCCUS-AUREUS; CULTURE BILAYER MODEL; INVITRO KINETIC-MODEL; PSEUDOMONAS-AERUGINOSA; STREPTOCOCCUS-PNEUMONIAE; ESCHERICHIA-COLI; BACTERICIDAL ACTIVITY; ANTIMICROBIAL AGENTS; AMPHOTERICIN-B; KILL KINETICS;
D O I
10.1093/jac/dkp434
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
In vitro pharmacodynamic (PD) models are used to obtain useful quantitative information on the effect of either single drugs or drug combinations against bacteria. This review provides an overview of in vitro PD models and their experimental implementation. Models are categorized on the basis of whether the drug concentration remains constant or changes and whether there is a loss of bacteria from the system. Further subdifferentiation is based on whether bacterial loss involves dilution of the medium or is associated with dialysis or diffusion. For comprehension of the underlying principles, experimental settings are simplified and schematically illustrated, including the simulations of various in vivo routes of administration. The different model types are categorized and their (dis)advantages discussed. The application of in vitro models to special organs, infections and pathogens is comprehensively presented. Finally, the relevance and perspectives of in vitro investigations in drug discovery and clinical research are elucidated and discussed.
引用
收藏
页码:186 / 201
页数:16
相关论文
共 164 条
[1]   In vitro activities of daptomycin, arbekacin, vancomycin, and gentamicin alone and/or in combination against glycopeptide intermediate-resistant Staphylococcus aureus in an infection model [J].
Akins, RL ;
Rybak, MJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (07) :1925-1929
[2]   INVITRO MODEL SIMULATING THE FORM OF EXPOSURE OF BACTERIA TO ANTI-MICROBIAL DRUGS ENCOUNTERED IN INFECTION [J].
ALASADI, MJS ;
GREENWOOD, D ;
OGRADY, F .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1979, 16 (01) :77-80
[3]   Activities of mutant prevention concentration-targeted moxifloxacin and levofloxacin against Streptococcus pneumoniae in an in vitro pharmacodynamic model [J].
Allen, GP ;
Kaatz, GW ;
Rybak, MJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (08) :2606-2614
[4]   In vitro activities of quinupristin-dalfopristin and cefepime, alone and in combination with various antimicrobials, against multidrug-resistant staphylococci and enterococci in an in vitro pharmacodynamic model [J].
Allen, GP ;
Cha, R ;
Rybak, MJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (08) :2606-2612
[5]   Evaluation of two in vitro pharmacodynamic simulation models:: Microfiltration versus centrifugation-filtration [J].
Alou, L ;
Sevillano, D ;
Bugella, JH ;
Fuentes, F ;
Gómez-Lus, ML ;
Prieto, J .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2001, 17 (05) :365-370
[6]   New approach for accurate simulation of human pharmacokinetics in an in vitro pharmacodynamic model:: application to ciprofloxacin [J].
Ba, BB ;
Bernard, A ;
Iliadis, A ;
Quentin, C ;
Ducint, D ;
Etienne, R ;
Fourtillan, M ;
Maachi-Guillot, I ;
Saux, MC .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2001, 47 (02) :223-227
[7]   Activities against Streptococcus pneumoniae of amoxicillin and cefotaxime at physiological concentrations: In vitro pharmacodynamic simulation [J].
Balcabao, IP ;
Aguilar, L ;
Martin, M ;
Garcia, Y ;
DalRe, R ;
Prieto, J .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (12) :2904-2906
[8]   Caspofungin in combination with amphotericin B against Candida parapsilosis [J].
Barchiesi, Francesco ;
Spreghini, Elisabetta ;
Tornassetti, Serena ;
Giannini, Daniele ;
Scalise, Giorgio .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (03) :941-945
[9]   Pharmacological indices in antibiotic therapy [J].
Barger, A ;
Fuhst, C ;
Wiedemann, B .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 52 (06) :893-898
[10]   AN INVITRO MODEL FOR MONITORING BACTERIAL RESPONSES TO ANTIBIOTIC AGENTS UNDER SIMULATED INVIVO CONDITIONS [J].
BERGAN, T ;
CARLSEN, IB ;
FUGLESANG, JE .
INFECTION, 1980, 8 :S96-S102